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ABSTRACT
Radiation-induced damage to  normal t issues within the non- target
volume is a major limitation of tumor radiotherapy. Physical methods
to obtain superior spatial dose distributions use sophisticated
technology and are expensive. Large scale applications of these
technologies in a developing country like India; with a large number
of cancer patients, poor’ instrumental facilities and inadequate
infrastructure face several problems. Radiobiological research aiming
at developing simple, inexpensive and effective methods to increase
the differential  response between tumor and normal t issues should be,
therefore, strengthened.
Biological end-points are determined not only by the molecular
lesions produced due to the absorption of  the radiat ion energy but  also
by the cellular repair processes, which become operative in response
to lesions in the living system. Therefore, enhancement of repair
processes in the normal tissues and inhibition of the same in tumors
should considerably improve the therapeutic index of radiation
treatment. A combination of agents which can su$abIy  alter the
spectrum of important molecular lesions with modifiers of cellular
repair could be an effective strategy. Initial ezperiments using
halopyrimidines to increase repairable DNA lesions produced by
sparsely ionizing radiat ions in  combinat ion with 2-deoxy-D-glucose  to
modulate differentially the repair and fixation processes in the tumor
and normal t issues have provided promising results .  Further research
work is warranted since this strategy appears to have great potential
for improving tumor radiotherapy.
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1. INTRODUCilON
The advent of artificial radiation sources and progress in the medical radiation
technology have led to a steady increase in the use of radiations in almost all spheres
of health care. Particularly, the present day management of cancer involves
radiation-based techniques in a crucial way for the detection, localization as well as
curative and palliative therapy of tumors. In principle, radiation should be able to
control localized cancer provided sufficiently high absorbed dose can be administered.
However, because of inability to selectively irradiate the tumor, normal tissues adjacent
to the tumor also receive high radiation dose and are damaged. Thus, the major cause
of failure of radiotherapy or treatment related morbidity is radiation damage induced
in non-target tissues.
The absorbed radiation dose to the normal tissues can be reduced by using several
new technical innovations for improving spatial dose distribution, for example, by
conformation therapy employing multiple leaf collimators in conjunction with
computerised 3-D treatment planning and image processing systems. Irradiation with
heavy charged particles such as pions, protons or helium ions is another possibility
which permits very precise dose delivery to the target volume with minimum dose to
the surrounding tissues. The accelerators needed for producing high energy particles
are, however, extremely expensive, restricting the establishment of such facilities in
only a few centres in the economically and technically advanced countries.
In India, the number of new cancer patients needing treatment has been estimated
to be of the order of 5 X 105patients per year. The major types of cancer prevalent
in the country, viz. oral, cervical and breast, can be cured by radiotherapy alone, if
detected at an early stage. However, the facilities available for radiotherapy in our
country are woefully inadequate and non-uniformly distributed. The majority of
machines are cobalt-60 teletherapy units (about 100) with a few electron accelerators
(8),  whereas the projected need is for 500 units. Only very few centres are equipped
for computerised treatment planning and imaging. The problems faced in the
development of the multidisciplinary speciality of radiation oncology in India have
been recently highlighted’. Applications of highly sophisticated, expensive and
potentially hazardous technologies in a developing society with inadequate
infrastructure, poorly trained personnel and limited resources face special problems.
There is a great need, therefore, to improve the management of the radiotherapy
departments and to use the existing technology prudently to ensure optimal benefit
to the patients.
From a long-term perspective, earnest efforts to develop more effective yet less
hazardous, simple and inexpensive techniques are required, if both the rural and
urban populations are to be provided with adequate treatment facilities in future. To
achieve this objective, basic research is necessary for better understanding the
biophysical processes underlying various aspects of radiation oncology. In this
presentation, some of the research strategies, which in the author’s view, appear to
be relevant with reference to the prevalent Indian conditions, will be discussed.
However, before undertaking this task, a few general remarks regarding the application
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of science and technology for social development are presented in order to provide
an appropriate framework for further discussions and action.
2. SCIENCE, TECHNOLOGY AND SOCIAL DEVELOPMENT
The multiple and complex relationships between research in basic sciences,
development of technology and its applications for the benefit of the society are shown
in Fig. 1. Research in basic sciences systematically attempts to determine truth, thereby
leading to generation of new knowledge. Advances in knowledge are necessary for
the development of new technology and industry. New technology, if used with
responsibility, can be exploited for the benefit of the society.
Translation of advances in knowledge into new technology and industrial
development in a reasonably short time span requires cooperation and coordination
between a large number of individuals, institutions, organisations and industry. This
difficult task can be accomplished only within a flexible and progressive system which
encourages easy (with minimum bureaucratic and administrative delay) multiple
linkages between research institutes, universities, industry and consumer
organisations.
In the absence of any worthwhile development of indegenous technology in the
field of radiation medicine in India, we have to depend almost entirely on the transfer
of technology from the advanced countries. The successful acceptance and optimal
use of any new technology by the society depends, however, upon a number of factors
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Figure 1. Relationships between science, technology and social  development.
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including industrial infrastructure, socio-economic and cultural backgrounds besides
considerations of technical merits (as compared with the existing technologies) and
associated hazards and risks. In order to objectively *evaluate the suitability of the
new technology, a total cost-benefit analysis should be carried out. Such an analysis
would be helpful in optimizing the use of the technology. Optimization requires that
the total cost-benefit ratio, 0,,  for application in a given situation be minimised. The
total cost includes not only the economic costs involved in the application of the
technology, but also the cost of the associated hazards and risks.
Adoption of the technology for regular use will be determined by the index of
affordability, which may be represented by a critical threshold value 0c  dependent
upon the resources of the society. For a wide acceptance of the technology 0= >> 0,.
The calculation of the cost of the hazards, risks and benefits is complex, since it
may also depend upon the value systems of the society. Attempts to estimate 0r
values under different conditions for alternate technological approaches are necessary
to objectively compare the alternatives and to help the planners and decision makers.
3. OPTIMIZING USE OF RADIATIONS IN CANCER MANAGEMENT
Within this framework, the present and future prospects of different strategies
for optimizing applications of radiation in cancer management in a developing country
like India should be examined. It is desirable to develop methods to reduce 0,. This
could be attempted in a number of ways by (i) reducing the cost of required equipments,
(ii) using the existing technology prudently, and (iii) carrying out research to develop
better and cheaper technology suited to the Indian environment.
3.1 Reduction in the Economic Cost of the Equipment and Prucedures
Cost of most equipment depends upon the industry and market forces. In our
country, the field of biomedical instrumentation, has not developed as an industry.
Consequently, the users have to rely entirely on imports. The foreign companies quote
special prices for India, which are higher, by at least 20-50 per cent than the local
price. Furthermore, for subsequent maintenance and servicing, the foreign companies
or their Indian agents charge exorbitant rates, In view of the increasing demand of
the sophisticated equipment in the field of radiation medicine, it is suggested that
adequate financial and human resources be mobilised to encourage inclegenous
research, development and manufacture of these equipment suited to the local
environment and needs.
3.2 Prudent Use of the Existing Technology
The attitudes and behaviour of health care professionals determine to a great
extent the use or misuse of the technology. Through proper education and training,
it must be ascertained that the medical practitioners:
(a) avoid using the technology when not necessary;
(b) avoid using the more expensive techniques, when the same information and
benefit can be obtained through simpler and cheaper techniques;
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(c) use the technique properly and ensure proper quality control to derive the
maximum benefit; and
(d) give due consideration to the potential hazards of the teehnology and
methods employed and take appropriate precautions to minim&  the
hazards.
3.3 Radiobiological Research for Improving Tumor Radiotherapy
The goal of radiobiological research is to understand the effects of radiations on
the biological systems and use this knowledge to increase the differential between the
radiation responses of the tumor and normal tissues so that a high probability of cure
without any significant morbidity at a given radiation dose can be achieved (Fig. 2).
Considerable work to develop radioprotectors for normal tissues and
radiosensitizers for the tumor has been going on throughout the world for more than
four decades. A large number of physical, chemical and biological agents have been
screened (for example, see Uma Devi2  and Singh3  for recent reviews). Inspite of
significant research effort, the success of these radiomodifiers in improving
radiotherapy has been rather limited so far. Enormous complexity of the problem,
gaps in the basic understanding of the processes determining the radiation responses
of the living systems coupled with the large inter- and intra-tumoral heterogeneity
displayed by human cancers (even of the same type) could be some of the reasons
for the slow progress. A critical review of the literature, however, reveals that a lack
of systematic, integrated and holistic approach and greater reliance on hit and trial
methodology with little emphasis on understanding the basic processes, could also be
partially responsible for the sub-optimal results. Recent progress in molecular genetics
and development of powerful non-invasive techniques to study structures and functions
in the intact organism appear promising to adopt a new approach and to fokulate
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a coordinated research programme to achieve the above mentioned desirable yet
elusive goal. The rationale of this approach is briefly presented in the following.
3.3.1 Radiation-Induced Biological Damage and Strategies to Improve Tumor
Radiotherapy
The biological damage induced by ionizing radiations evolves through a complex
network of processes occurring at various levels of organisation and extending over
a large time scale (Table 1). For simplicity, we may identify two important stages
comprising (i) physico-chemical processes leading to the production of lesions in the
biomolecules, and (ii) biological processes representing the responses of the living
system to the molecular lesions. Both these phases can be suitably influenced in a
number of ways to optimize tumor radiotherapy.
(a) Induction of biomolecular  lesions
Absorption of radiation in biological tissues gives rise to excitations and ionizations
of atoms and molecules resulting in the formation of highly reactive ion radicals and
free radicals which may interact with each other and with other molecules. Some of
these reactions may result in the induction of relatively long-lived lesions in important
biomolecules. All types of biomolecules including nucleic acids, proteins, lipids and
carbohydrates have been shown to be damaged by ionizing radiations. It is now
generally agreed that DNA is the most important target for radiation-induced ceil
death while damage to molecules in biomembranes may also play a role under certain
conditions. The most important DNA lesion responsible for cell death is the double
strand break (DSB), which is readily repairable in mammalian cells4Y5.
The spectrum of molecular lesions induced depends upon the quality of radiation,
microenvironment, structures and conformations of the molecules involved.
The quantity and pattern of energy depositions are primarily determined by the
radiation quality and the irradiation technique. Passage of radiation through matter
results in stochastically distributed energy depositions along the tracks of the ionizing
particles. Biological damage, however, is influenced by the density of energy deposition
along the particle track. Two small energy depositions, produced by chance in a short
distance, may act in a biological macromolecule as one large energy deposition leading
to a more severe, h-repairable lesion in the molecule than would be expected by single
small energy depositions (repairable lesions). Therefore, densely ionizing radiations
(neutrons and heavy ions) are biologically more effective than sparsely ionizing
radiations (photons, electrons). Use of heavy charged particles offers many advantages
because of their superior depth-dose distribution showing a narrow peak towards the
end of their range (Bragg peak) with high relative biological efficiency (RBE) and
small lateral scattering. However, production of these particles is prohibitively
expensive, as mentioned already in the introduction.
During irradiation with sparsely ionizing radiations, such as fast electrons or
gamma rays, indirect action for producing macromolecular lesions may become
important. Since 743-80  per cent of biological mass consists of water, reactions with
radiolysis products of water, (*OH, H, eq, etc)  in particular, free radicals and active
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oxygen species contribute significantly to the production of molecular lesions. It has
been estimated that 60-65 per cent of cell lethality observed after exposure of eukaryotic
cells to sparsely ionizing radiations (low-LET) may be due to lesions induced by
indirect effects (.OH  mediated); for densely ionizing radiations (high-LET) this may
decrease to about 20 per cent‘*’  Thus the probability of radioprotection by efficient.
scavengers of hydroxy radicals is great& with low-LET radiations than with high-LET
radiations.
Radioprotectors
Free radical scavengers and antioxidants have, therefore, been studied extensively
as radioprotectors in various model systems. The largest number of compounds acting
as free radical scavengers and tested for radioprotection are aminothiols, being
chemical analogs of the naturally occurring sulfur-containing amino acid cysteine,
which was amongst the earliest substances investigated’. Guanido derivative of
cysteine, aminoethylisothiouronium bromide (AET) was shown to reduce the effect
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of a radiation dose by a factor of 2.1 in mice’, however, it was,found  unsuitable for
human use because of high toxicity. The toxicity of AET can be reduced by combining
with other thiol compounds“pi A combination of AET with 5hydroxytryptophan.
(5HI’)  appears tobe promising; it has been shown to give better protection
less toxic”.
Synthesis of a phosphorylated aminothiol known as WR-2721 by the Walter Reed
Army Institute’s research programme was a significant advance12. WR-2721 has been
reported to show a dose reduction factor (DRF) of 2.7 in mice when injected
intraperitoneally 30 minutes before irradiation. WR-2721 has been studied widely
during the last two decades and has been shown to protect different normal tissues
to various extents wiih generally low protection to tumors13.  For this reason, clinical
trials on human patients have been initiated inspite of some of the side effects observed
in animal as well as human studies 14,15  Research is in progress to develop less toxic.
analogs or to combine WR-2721 at subtoxic doses with other compounds which may
act additively or synergistically. For example, experiments on mice suggest that
combination of low doses of WR-2721 with administration of 2-mecaptopropionyl
glycine (MPG) could be effective in providing significant protection without serious
toxicity16.
Radiosensitizers
A number of studies have also been made to develop radiosensitizers for tumor
cells. Amongst a large number of compounds investigated, clinical trials have been
carried out using hyperbaric oxygen, electron affinic agents, in particular
nitroheterocyclics metronidazole and misonidazole, to sensitize hypoxic cells.
The use of hyperbaric oxygen is very cumbersome. Results of clinical trials with
metro- and misonidazoles have shown serious neurotoxicity with little therapeutic
benefiti7. Attempts are now being made to develop less toxic analogs.
Since, biomembranes, besides DNA, could also be important critical targets for
radiation-induced biological damage*8*19,several drugs and chemicals which are known
to act specifically on membranes, have been investigated; a few have been shown to
modify radiation effects. Phenothiazines, in particular trimeprazime (TMZ) and
chlorpromazine (CPZ) , have shown siginificant radiosensitization of hypoxic tumor
cells and protection of euoxic cells”. .Experiments on animal models have also shown
promising results. The mechanisms of action remain to be elucidated. Since these
drugs are already being used in clinical practice as tranquilizers, theirpharmacokinetics
are well known and clinical trials can be initiated.
DNA base analogs such as halopyrimidines have been used to increase the
radiation sensitivity of proliferating tumor cells. Halogenated pyrimidine analogs like
5-bromo-deoxyuridine  (BrdU)  and 23 iododeoxyuridine (IdU)  can be incorporated
in DNA in place of thymidine in the proliferating cells21. It has been shown that the
incorporation of these analogs into the DNA, increases the radiation-induced DNA
strand breaks, chromosome aberrations, micronuclei and cell deathhusm. The increase
in DNA strand breaks is supposed to occur via the production of highly reactive
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uracilyl radical-due to the interaction of radiation-produced hydrated electron with
BrdUz5.  The uracilyl radical in DNA abstracts a hydrogen atom from the nearby
deoxyribose in the same or the opposite strand, resulting in the formation of a single
strand DNA break.
Clinical trials using halopyrimidines were initiated in,USA and Japan in the early
sixties26,27  but were abondoned because of problems of drug delivery andsevere normal
tissue toxicity. For significant radiosensitization, it is essential that sufficient amount
of halopyrimidines be incorporated in the tumor cell DNA. This requires the drug to
be administered for a long duration, since the cell-cycle times in most human tumors
are long. Using continuous intravenous infusions-over long periods of time, the clinical
trials have been started again by the National Cancer Institute, USA. The initial
results do not show any major improvement in case of treatment of glioblastoma
patients but the results in a few cases of unresectable  sarcomas are very
encouraging .28,29  In these studies also, systemic toxicity due to myelosuppression
appear to be the limiting factor. Attempts are being made to increase the incorporations
of halopyrimidines in the tumor and minimising in the normal proliferating tissues.
(6) Biological response modifiers
As an adaptive response to attack by cytotoxic agents, the biological systems
have developed various repair pathways acting at different organisational levels. These
repair pathways attempt to reverse the molecular lesions and ‘the tissue injury to
restore the original state. Modification of the repair pathways can profoundly influence
the biological effects of radiation. Thus, an inhibition of the repair processes in the
*tumor can increase the radiation-induced cell-killing and prevent the regrowth of the
tumor: Enhancement of the repair processes in the normal tissues; on the other hand,
can reduce the radiation-induced morbidity. Studies to understand the regulation and
control of repair Qathways  will be helpful in developing differential modifiers of
radiation response suitable for improving tumor radiotherapy. This will be discussed
in some detail in the remaining part of the present communication.
Intracellular repair
There is considerable experimental evidence to suggest that DNA, being the
carrier of genetic information, forms a prominent target for radiation-induced cell
death. We may, therefore, classify the molecular damage into DNA damage (A*)
and non-DNA lesions (A”). Following the formation of molecular lesions, different
cellular responses resulting in various biological consequences (Fig. 3) are possible.
(a) If the molecular lesions are completely reversed (error-free repair), the
damaged cells can return back to the original viable state (A).
(b)  If the DNA lesions are transformed into irrepairable forms (fixation) or
some errors are introduced during repair (misrepair), alterations and loss
of genetic information will result.
If the errors introduced during repair are not detrimental to cell proliferation,
mutated cell populations with altered functions (B) may be generated. Somatic cell
410 Viney Jain
mutations could give rise to cancer or lead to organ dysfunction and premature aging.
Mutations in the germ cells may cause genetic disorders in the subsequent generations.
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Processes of misrepair and fixation, associated usually with the processes of cell
proliferation, can also lead to chromosome aberrations and formation of micronuclei.
The loss of essential genetic information may not be compatible with cell proliferation
and survival resulting eventually in cell death (D) and cell loss from the system.
It is obvious from Fig. 3, that the cellular responses to ionizing radiations are
essentially determined by competitions between the pathways of (i) error-free repair,
(ii) misrepair, and (iii) fixation of radiation-induced DNA lesions. Therefore, suitable
modifications in the rates of repair and fixation pathways can alter the cellular radiation
responses.
Since DNA double strand breaks are thi major potentially lethal lesions induced
by ionizing radiation, inhibition of their repair should considerably increase cell death.
A number of inhibitors of DNA repair pathways are now available. Specific inhibitors
of DNA repair enzymes affect normal and transformed cells in a similar fashion and
no differential effects have been demonstrated as yet. Since normal and tumor tissues
differ in their cell kinetic organisation and patterns of metabolism, the possibility of
influencing rates of repair through modulation of cell proliferation and metabolism
has been studied by our group. In particular, the possibility of differential inhibition
of DNA repair in neoplastic cells in the presence of a glucose analog,
2-deoxy-D-glucose  (2-DG) ,  has been demonstrated in a number of model systems32”5.
Our basic studies to investigate the relationship between energy metabolism and
repair processes have shown that the rate of error-free DNA repair correlates with
the rate of energy production in a sigmoid manner, below a certain &t&&threshold
’
Radiomodifiers for Improving Cancer Therapy 411
value of the rate of energy production, DNA repair is completely inhibited. Rates of
misrepair and fixation of DNA lesions, which are associated with the processes of
cellular proliferation, can also be modified by the energy supply, but quantitatively
in a different way than the rates of error-free DNA repair. The differences lead to
the existence of cross-over points, which determine the direction of modification of
the cellular radiation response under conditions of energy deficiency. Thus, by
appropriate modifications of the energy supply, a reduction or an enhancement of
radiation injury to the system can be achieved.
2-DG is an inhibitor of glucose transport and glycolysis and therefore, its presence
drastically reduces the supply of metabolic energy in the tumor cells which depend
to a large extent on the glycolytic pathway for the production of adenosine-
triphosphate (ATP), the cellular energy currency. This state of energy deficiency
inhibits the rate of DNA repair in tumors. The normal cells, on the other hand, derive
most of the energy through the respiratory pathway and therefore, their energy supply
is only marginally affected by 2-DG, which is sufficient to reduce the rate of cell
proliferation and fixation of lesions, but DNA repair is not reduced significantly under
these conditions. Consequently, in the presence of 2-DG in normal proliferating cells,
for example bone marrow, the radiation damage is reduced considerably if 2-DG is
administered immediately before or after irradiation36.
These results suggest that 2-DG is a unique agent which can increase the
radiation-induced damage to tumor cells and reduce the damage to normal cells.
Therefore, to investigate the feasibility of using this antimetabolite in humans, clinical
trials on brain tumor patients have been initiated3’.
Intercellular repair and tissue regeneration
Superimposed upon the above mentioned repair pathways, additional mechanisms
of repair operate at the tissue level to compensate for the cell loss. A tissue is a
complex dynamic system composed of various types of cells in different physiological
states. From the point of view of cell kinetics, these cells can be broadly classified
into two categories, viz., (i) cycling cells, engaged in proliferative activity (P), and
(ii) non-cycling cells (Q and D), as shown in Fig.4.  The non-cycling cells can be either
permanently or temporarily out of cefS;cycle  and may be blocked in Go-,  Gi- or
G,-phases of the cell cycle (Q). Cells %ich .are  permanently non-cycling are the
differentiated mature functional cells (F) and der&ells ‘@)&ells, which are out of
cell cycle (Q) but retain the capability to re-enter the cycle (stem cells) comprise the
potential proliferative pool.
Living tissue is a dynamic system; new cells are being constantly produced while
some cells are being lost. A non-growing tissue of an adult organism is generally in
the steady state-the rate of cell birth and cell loss are constant and equal.
Non-cycling + cycling transitions and their regulations through negative feedback
controls provide adaptability to return back to the steady state after perturbations.
For example, upon irradiation (Fig. 4(b)), many cells may be killed resulting in an
increase in the cell loss. To compensate for the cell loss, the rate of cell proliferation
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should increase so that tissue can be repopulated. This can be done in two ways: (i)
by reducing the cell cycle time, and (ii) by stimulating the-non-cycling cells to re-enter
the cell cycle (recruitment). Both these phenomena have been observed to occur in
tumors and normal tissues and represent important mechanisms of intercellular or
tissue repair.
The tissue regeneration capacity depends upon the number of surviving stem cells
and the successful completion of the recruitment process. The recruitment process
depends upon complex interactions of various biochemical reactions involved in the
signal transduction by small molecules such as cytokinines, growth stimulating factors
and receptor mediated mechanisms on the cellular membranes. Recent work has
shown that certain immunomodulators such as glucan (8-1,3  polyglucose isolated from
the yeast, Sacchuomyces  cerevesiae) and interleukin-1 (IL-l) can significantly enhance
the recruitment of stem cells in the bone marrow of whole-body irradiated mice,
thereby considerably increasing their survival38*39 These findings are of great interest.
for protection against radiation and treatment of radiation injuries.
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The effects of these modulators on tumors remain yet to be investigated. Our
preliminary studies suggest that 2-DG could differentially inhibit the. recruitment
process in cell populations exhibiting high rates of glycolysis40.  Thus, the increase in
radiation induced tumor regression in mice could be partially explained on this basis41
as shown schematically in ,Fig.  4(c). Further work to study this possibility needs to
. be carried out.
The above considerations suggest that it may be possible to develop agents which
can stimulate the regeneration of normal tissues after radiation injury and inhibit the
repopulation of tumors preventing thereby their regrowth after radiotherapy.
Combination of different strategies
The approaches discussed above are not mutually exclusive and for optimal results
combination of different strategies should be attempted. A combination of free radical
scavengers and radiosensitizers with biological response modifiers could give additive
or synergistic effects. Initial attempts in this direction are quite encouraging. Thus a
combination of WR-2721 given before irradiation with soluble glucan administered
. post-irradiation has shown greater than additive effect42. Similar results have been
reported for the combination of WR-2721 with IL-143.
The radiosensitizing effects af halopyrimidines have been observed to be enhanced
in tumor cells in the presence of 2-DG* and reduced in normal bone marrow cells
of mice45*46;  Therefore, the differential between radiation-induced cell-killing in tumors
and normal tissues can be significantly enhanced by combining halopyrimidines and
2-DG administration with radiation treatment.
A number of new combinations are being studied.
4. FUTURE PROSPECTS
The above discussion shows that the major problems encountered~with the use
of present day radioprotectors and radiosensitizers in clinical radiotherapy concern
the toxicity of these agents and inadequate differential effects between the tumor and
the normal tissues.
The new approach. of combining radioprotectors and radiosensitixers with
biological response modifiers appears to be promising. The search for an effective
and non-toxic combination of radiomodifiers will be greatly facilitated by a better
understanding of the processes involved in the biological responses of tumors and
normal tissues to radiation induced molecular lesions. Repair, of DNA damage and
the recruitment of stem cells in the cell-cycle are of particular interest in this respect.
Using techniques of molecular biology, it should be possible to identify the genes
(DNA sequences) which code for the various repair enzymes and to study the regulation
and control of their expression. The knowledge thus gained will be helpful in developing
methods to modulate the contents and activities of repair enzymes appropriately to
achieve enhancement of repair in normal and inhibition of repair in tumor cells. Use
of 2-DG to increase the differential effects of cytotoxic agents between tumors and
normal tissues is also a step in this direction, though it exploits the differences in the
414 Viney Jain
cellular energy and nucleotide metabolism. Further research work to study the exact
mechanisms involved and to carry out clinical trials is warranted.
Non-invasive imaging techniques should be exploited to study and monitor the
radiation responses of various tissues in the intact organism. The problems connected
with tumor heterogeneity and development of radiation resistance could be better
investigated using the non-invasive methods. Improved understanding of tumor biology
will be crucial in the development of more effective and simpler therapeutic regimens.
Thus, radiobiological research *may eventually achieve the goal depicted in
Fig. 2 by developing suitable modifiers of radiation response. If this endeavour is
successful, it may be possible to treat local and metastatic malignant disease with
whole-body irradiation without,any serious toxic effects on normal tissues and without
the need for expensive high technology machines. Needless to say that such a
development will eminently suit the Indian environment and would go a long way
towards the goal of providing health care to all by the year 2000.
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